Lasers for Science Facility (LSF)

Yes

​​​​

The CLF’s Lasers for Science is a multidisciplinary user facility that provides world-leading scientific capabilities for the benefit of UK research and innovation.
No

The CLF’s Lasers for Science Facility (LSF) is a multidisciplinary user facility that provides world-leading scientific capabilities for the benefit of UK research and innovation. 

It consists of Octopus (laser-based microscopy for bioimaging), Ultra (ultrafast spectroscopy) and Artemis (imaging and spectroscopy with extreme ultraviolet light). These facilities are internationally recognised and, in many cases, offer unique or bespoke capabilities that are unavailable elsewhere in the UK, Europe, and in some instances globally. The facility is an open-access National user facility and operates a “free-at-point-of-use” access model, with access awarded through independent peer review.

Close up of optics with green light shining off them.User access

  • delivers 186 weeks of peer-reviewed access in ~60 experiments each year

  • 1.7 times over-subscribed at access calls

  • 318 departme​nts of 156 institutions (76 in UK) have accessed Lasers for Science in past decade

  • all Russell Group universities except LSE have used Lasers for Science

  • publications include collaborations with 178 organisations, including 67 UK organisations and 111 international partners


Outputs

  • produces around 50 scientific publications each year

  • approx 30% of publications produced over the last five years have appeared in journals with a Citation Impact Factor of 7 or above

  • high impact journals include Physical Review Letters, Science Advances, Journal of the American Chemical Society, Nano Letters, Nature Communications, PNAS, Chemical Science, Nature Neuroscience

Support for funded research

  • over the last 5 years, LSF has supported researchers who have been awarded over 80 UKRI grants totalling >£110M in value
  • 60% ​of facility access supported UKRI grant-funded research
  • 14% of access has non-UK funding, including the ​European Commission, BMBF, CNRS, CNR, NSF and NIST

​​​​​​​Research Are​a

Applications

Biology, biomedicine and health

  • cellular and molecular biology (cancer, kidney disease, immune signalling)
  • mechanistic understanding of health and disease

Biophotonics and photomedicine

  • light-matter interactions in biological systems
  • physics-driven approaches to biology and medicine

Chemical dynamics and photochemistry

  • ultrafast chemical and photophysical processes (photovoltaics)
  • fundamental understanding of how molecules behave over time

Catalysis and sustainable chemistry

  • photocatalysis and electrocatalysis
  • industrial and energy-relevant reaction mechanisms

Materials and energy science

  • functional materials (polymers, nanomaterials, metal complexes)
  • 2D surfaces and quantum materials

Electrochemistry and interface science

  • electrode-electrolyte interfaces (batteries)
  • surface reactions and interfacial dynamics
  • links chemistry to real-w​orld devices and processes

Environmental and atmospheric science

  • aerosols and atmospheric chemistry
  • pollutant photochemistry and degradation
  • ​environmental health impacts (e.g. air pollution effects)

Soft matter and complex systems

  • liquids, dr​oplets, thin films, and nanoscale interfaces
  • fundamental behaviour of disordered and interfacial systems

Biomaterials and bioengineering

  • hydrogels, organoids, and tissue models
  • ​enables translational and regenerative applications

Cultural heritage

  • ​a​rt and archaeology
  • natural history and conservation


Percentages of LSF access by research discipline (2020-2026) 2.pngAlignment with industrial strategy

  • advanced manufacturing: batteries

  • clean energy: photovoltaics

  • digital and technology: quantum technology and semiconductors

  • life sciences: cancer therapies, pharmaceuticals and medical technologies​

Industry and innovation

  • home of Cobalt, STFC’s most successful spinout, which was acquired by Agilent and played a significant role in attracting Agilent to the Harwell Campus

  • 3% commercial access​


SORS-vaccine.jpg

Image: Scientist using a Cobalt-Agilent scanner to assess the contents of a vaccine vial

Income and investment

  • £4.2M annual operating budget (including staff costs)
  • total installed Capital value ~ £35M. UKRI, STFC, EPSRC, BBSRC funded
  • received £17.2M from the UKRI infrastructure fund for the HiLUX upgrade over 2023-2028
  • funding from CRUK, The Guy Foundation, Wellcome Trust

International links

  • 111 international partners spanning 32 countries across six continents

  • funded access for EU and international users provided through Horizon Europe’s Laserlab-Europe and Lasers4EU programmes

  • collaborations with other international facilities including EuXFEL, LCLS, MAX IV, SACLA, ELI-Alps and ELI Beamlines

Staff​

  • 49​ scientists (40% female and 30% early-career), supported by 8 engineers

  • multidisciplinary expertise (Physics, Chemistry, Biology, Computing, Astronomy, Materials Science)​


Laser facilities

​Find further information on LSF's laser facilities including specifications, publications, instruments and staff.​

  • Ultra laser

Case studies

​Examples of the impactful collaborations, research and discoveries using LSF facilities and expertise.

  • LightOx scientist working in Octopus lab